If you take Ozempic (semaglutide) or another GLP-1 medication , discontinue use three weeks before your colonoscopy due to anesthesia concerns
Animal models of diabetic retinopathy
Danone shares rose 7% after Q2 sales results exceeded expectations, driven by a 40% sales increase for the Oikos line in North America
adults are affected by obesity, while the World Health Organization estimates that 1 billion people globally are living with obesity, reinforcing strong demand for GLP-1 drugs as effective pharmacological solutions for weight management and metabolic health improvement
2024 DOI: 10.1038/s41421-024-00702-y PMID: 39019866 Read on PubMed European Journal of Clinical Pharmacology A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity Kaur M, Misra S 2024 DOI: 10.1007/s00228-024-03646-0 PMID: 38367045 Read on PubMed Cardiology in Review The First Triple Agonist for Antiobesity: Retatrutide Tetelbaum L, Mullally JA, Frishman WH 2024 DOI: 10.1097/CRD.0000000000000793 PMID: 39724554 Read on PubMed NPJ Metabolic Health and Disease Incretin triple agonist retatrutide alleviates obesity-associated cancer progression Marathe SJ, Grey EW, Bohm MS, et al